Patent Grant
11759489
This application is a National Stage of International Application No. PCT/KR2019/010687 filed Aug. 22, 2019, claiming priority based on Korean Patent Application No. 10-2019-0050164 filed Apr. 30, 2019.
The present invention relates to a food composition and a pharmaceutical composition for promoting height growth comprising a Humulus japonicus ingredient as an active ingredient.
In our society, due to recent economic growth, the growth conditions of infants, children, and adolescents have been greatly improved by improvement in nutritional status and changes in dietary habits. In general, the meaning of growth is often limited to an increase in height, but medically, the morphological and anatomical sizes and functions are increased, and the growth involves that the skeleton and muscles are enlarged and strengthened, and such growth is achieved by the action of hormones.
As methods for promoting the growth, methods such as administration of growth hormone preparations, Ilizarov surgery, and the like have been known, but these methods are very concerned about the accompanying side effects, and methods such as administration of health functional foods have disadvantages of not providing sufficient effects.
In other words, the administration of growth hormones may cause various side effects, such as leukemia, hypothyroidism, hyperglycemia, central nervous system tumors, diabetes and epilepsy, etc. In addition, the Ilizarov surgery is a surgical method that is mainly used when the lengths of both lower limbs are asymmetric, but when the surgery is performed on a normal and short person, serious side effects may occur to prevent normal walking.
In recent studies, a method of using natural substances is attracting attention as a method of safely inducing the growth while avoiding side effects from administration of growth hormones and side effects from surgery. Specifically, a method for ultimately inducing height growth by stimulating the secretion of growth hormones by naturally ingesting natural substances has been found, and accordingly, the search for the natural substances is being actively conducted.
However, despite the active research activities as described above, natural substances capable of providing a substantial effect on height growth have been not yet reported.
Korean Laid-open Patent Publication No. 10-2014-0057709
The present inventors have made many efforts to solve the above problems, found a plant having an excellent activity in promoting height growth as a medicinal plant that has been used for various symptoms in the related art and a method capable of enhancing its activity, and then completed the present invention.
Therefore, an object of the present invention is to provide a composition for promoting height growth capable of efficiently promoting the height growth without side effects by using a natural substance.
In order to achieve the object, the present invention provides a composition for promoting height growth comprising a Humulus japonicus ingredient as an active ingredient.
In an embodiment of the present invention, the composition for promoting the height growth may further comprise at least one selected from the group consisting of watermelon and garlic.
In an embodiment of the present invention, at least one selected from the group consisting of watermelon and garlic may be a watermelon/garlic concentrate processed in the form of concentrate prepared by mixing watermelon and garlic in a weight ratio of 1:9 to 9:1.
In an embodiment of the present invention, the composition for promoting the height growth may be used as a pharmaceutical composition or food composition.
According to the present invention, the composition for promoting the height growth comprises a Humulus japonicus ingredient having a very excellent activity for promoting the height growth or a watermelon and/or garlic ingredient enhancing a height growth promoting effect by providing synergy with the Humulus japonicus ingredient in addition to the Humulus japonicus ingredient to provide a very excellent effect on the height growth of children and adolescents in a growth period.
Terms used in the present invention are terms defined in consideration of functions in the present invention, and may vary according to the intentions of users and operators or customs, and thus, definitions of these terms should be made based on the technical contents throughout the present specification. On the other hand, embodiments are only exemplary matters of components presented in the appended claims of the present invention, and do not limit the scope of the present invention, and the scope of the present invention should be interpreted based on the technical idea throughout the specification of the present invention.
Hereinafter, the present invention will be described in more detail.
The present invention relates to a composition for promoting height growth comprising a Humulus japonicus ingredient as an active ingredient.
The Humulus japonicus ingredient may be at least one selected from the group consisting of a processed product containing a Humulus japonicus substrate and a Humulus japonicus extract, but is not limited thereto. For example, it should be understood that Humulus japonicus processed in the form of use of a medicinal plant known in the art is all included in the Humulus japonicus ingredient.
The processed product containing the Humulus japonicus substrate includes, for example, a processed product obtained by drying or steaming Humulus japonicus, and a processed product (crushed product) in a pulverized or crushed form. However, the processed product is not limited thereto, and it should be understood that all processed forms containing the Humulus japonicus substrate are included in the processed product containing the Humulus japonicus substrate of the present invention.
The Humulus japonicus extract may be, for example, an extract extracted with at least one solvent selected from the group consisting of water, alcohol, acetone, and ethyl acetate. In particular, among these extracts, extracts extracted with hot water may be preferably used.
Ethyl alcohol (ethanol) may be preferably used as the alcohol.
The Humulus japonicus used in the present invention is also called Yulcho, Galryulman, and Galryukman, and has been known as Humulus japonica Sidb. et Zucc. or H. scandens Merr. The Humulus japonicus grows by the brook and the road and at the foot of a mountain in various places, and is usually used by cutting the turning leafy in summer and drying the cut turning in the shade.
The Humulus japonicus is known to have a sweet and bitter taste and a cold nature, and to lower heat, detoxify, eliminate bloodstasis, and give urine well. Through pharmacological experiments, coercive action, diuretic action, and inhibitory action against Gram-positive bacteria have also been found.
Also, it is known to be effective when a patient has a fever, feels stuffy, and thirsty; when a patient has a fever due to malaria and tuberculosis; and in digestive disorders, acute gastritis, edema, diarrhea, dysentery, cystitis, urethritis, pregnancy, urethral stones, hypertension, boils, and the like.
However, until now, it has not been known at all that the Humulus japonicus has a height growth promoting activity. This fact has been confirmed through clinical trials while the inventors of the present invention operate an oriental medicine clinic, and has been more scientifically proven through experiments and the like conducted for the filling of the present invention.
The Humulus japonicus may use at least one selected from leaves, sprouts, stems, and roots, and the Humulus japonicus extract is more preferably extracted from, particularly, leaves and sprouts.
The composition for promoting the height growth of the present invention may further comprise at least one selected from the group consisting of watermelon and garlic in addition to the Humulus japonicus ingredient.
At least one selected from the group consisting of watermelon and garlic causes a synergistic effect with the Humulus japonicus ingredient, and thus, performs a function of enhancing the activity of the Humulus japonicus ingredient.
At least one selected from the group consisting of watermelon and garlic may be preferably used to be processed in a concentrate form. The preparation of the concentrate may be performed by methods known in the art.
In particular, the watermelon/garlic concentrate, which is processed in the concentrate form by mixing watermelon and garlic in a weight ratio of 1:9 to 9:1, exhibits an excellent synergistic effect with the Humulus japonicus ingredient. Therefore, it is preferred to use this concentrate form together with the Humulus japonicus ingredient. The mixing weight ratio of the watermelon and garlic is more preferably 2:8 to 5:5.
The watermelon/garlic concentrate may be prepared by a method for producing a concentrate known in the art. Particularly, the watermelon/garlic concentrate may be preferably prepared by a process of heating while applying a pressure of 1 to 1.5 kg in a pressed cooker.
The heating may be performed at a temperature of 50° C. to 200° C., more preferably 100° C. to 180° C., and much more preferably 150° C. to 170° C. The heating may be performed at a time of 1 to hours, more preferably 10 to 20 hours, and much more preferably 14 to 18 hours.
In the present invention, the Humulus japonicus ingredient and at least one selected from the group consisting of watermelon and garlic may be included in a weight ratio of 1:9 to 9:1, preferably 2:8 to 9:1, more preferably 5:5 to 9:1, much more preferably 7:3 to 9:1.
When the Humulus japonicus ingredient and at least one selected from the group consisting of watermelon and garlic are included in the aforementioned range, it is preferable because the height growth promoting activity may be maximized by the synergistic effect of the respective ingredients.
The composition for promoting the height growth of the present invention may be used as a pharmaceutical composition or a food composition.
When the composition for promoting the height growth of the present invention is used as the pharmaceutical composition, the composition may further comprise at least one additive selected from the group consisting of a pharmaceutically acceptable carrier, an excipient, and a diluent. As described above, the types and amounts of additives additionally included in the pharmaceutical composition of the present invention are followed as commonly known in the related art.
The pharmaceutical composition may comprise a pharmaceutically acceptable carrier. The composition comprising the pharmaceutically acceptable carrier may be formulated into various oral or parenteral formulations.
For the formulation, a diluent or an excipient may be used, such as a filler, an extender, a binder, a wetting agent, a disintegrating agent, a surfactant, and the like, which are generally used.
As the pharmaceutical composition, a solid formulation for oral administration includes a tablet, a pill, a powder, a granule, a capsule, and the like, and the solid formulation may be prepared by mixing at least one excipient, for example, starch, calcium carbonate, sucrose or lactose, gelatin, and the like with at least one compound. Further, lubricants such as magnesium stearate, talc, and the like may be used in addition to simple excipients.
A liquid formulation for oral administration may correspond to a suspension, an oral liquid, an emulsion, a syrup, and the like, and may include various excipients, for example, a wetting agent, a sweetener, an aromatic agent, a preserving agent, and the like, in addition to water and liquid paraffin which are commonly used as simple diluents.
A formulation for parenteral administration includes a sterile aqueous solution, a non-aqueous solution, a suspension, an emulsion, a lyophilizing agent, and a suppository.
As the non-aqueous solution and the suspension, propylene glycol, polyethylene glycol, vegetable oil such as olive oil, injectable ester such as ethyl oleate, and the like may be used.
As a base of the suppository, witepsol, macrogol, tween 61, cacao butter, laurinum, glycerogelatin, and the like may be used.
The pharmaceutical composition may be formulated and used to be suitable for an application form in the form of oral formulations such as tablets, pills, powders, granules, capsules, suspensions, oral liquids, emulsions, and syrups; and parenteral formulations such as aqueous solutions as sterilized injection solutions, non-aqueous solvents, suspensions, and emulsions, lyophilized preparations, suppositories, etc.
The route of administration of the pharmaceutical composition may be administered through any general route as long as the pharmaceutical composition can reach a target tissue. For example, according to a purpose, the pharmaceutical composition may be injected by intraperitoneal administration, intravenous administration, arterial administration, intramuscular administration, intraosseous administration, intrauterine administration, dural administration, subcutaneous administration, intradermal administration, oral administration, intranasal administration, intrapulmonary administration, rectal administration, and intracerebroventricular administration, but is not limited thereto. In addition, the pharmaceutical composition may be administered by any device capable of transferring an active ingredient to a target cell.
The pharmaceutical composition may be administered in a pharmaceutically effective dose. In the present invention, the term “pharmaceutically effective dose” refers to a amount enough to treat diseases at a reasonable benefit/risk ratio applicable to medical treatment, and an effective dose level may be determined according to elements including a kind of subject, the severity, age, gender, a type of infected virus, the activity of a drug, sensitivity to a drug, a time of administration, a route of administration, an excretion rate, duration of treatment, and drugs to be simultaneously used, and other elements well-known in the medical field.
The pharmaceutical composition may be administered as an individual therapeutic agent or administered in combination with other therapeutic agents, and sequentially or simultaneously administered with therapeutic agents in the related art. In addition, the pharmaceutical composition may be administered singly or multiple. It is important to administer an amount capable of obtaining a maximum effect with a minimal amount without side effects in consideration with all the elements, and the amount thereof may be easily determined by those skilled in the art.
The pharmaceutical composition may be used alone or in combination with surgery, hormone therapy, drug therapy, and methods using biological response modifiers for therapy for promoting height growth. The pharmaceutical composition may be used for preventing or treating dwarfism or nanism.
In addition, the composition of the present invention may be a food composition for promoting height growth.
The food composition may comprise an additional ingredient capable of commonly enhancing odor, taste, vision, and the like. For example, vitamins A, D, E, B1, B2, B6, B12, niacin, biotin, folate, panthotenic acid, and the like may be included. In addition, minerals such as zinc (Zn), iron (Fe), calcium (Ca), chromium (Cr), magnesium (Mg), manganese (Mn), and copper (Cu) may be included. In addition, amino acids such as lysine, tryptophan, cysteine, and valine may be included. In addition, the food composition may be added with food additives, such as preservatives (potassium sorbate, sodium benzoate, salicylic acid, sodium dehydroacetate, etc.), disinfectants (bleaching powder and highly bleaching powder, sodium hypochlorite, etc.), antioxidants (butylhydroxyanisole (BHA), butylhydroxytoleuene (BHT), etc.), colorants (tar color, etc.), coloring agents (sodium nitrite, etc.), bleach (sodium sulfite), seasoning (MSG sodium glutamate, etc.), sweeteners (dulcin, cyclamate, saccharin, sodium, etc.), flavorings (vanillin, lactones, etc.), expanding agents (alum, potassium D-bitartrate, etc.), reinforcing agents, emulsifying agents, thickening agents, coating agents, gum base agents, foam inhibitors, solvents, improving agents, etc. The additive is selected according to a type of food and used in an appropriate amount.
The food composition may be specifically a health functional food composition.
As a specific example, processed foods capable of promoting height growth may be produced using the food composition, and for example, the food composition may be produced as health functional foods in the forms of confectionery, beverages, alcoholic drinks, fermented foods, canned foods, processed milk foods, processed meat foods, or processed noodles. At this time, the confectionery includes biscuits, pies, cakes, bread, candy, jelly, gum, cereals (including meal substitutes such as grain flakes), and the like. The beverages include drinking water, carbonated beverages, functional ionic beverages, juices (for example, apple, pear, grape, aloe, tangerine, peach, carrot, tomato juices, etc.), sikhye, and the like. The alcoholic drinks include sake, whiskey, shochu, beer, hard liquor, and fruit liquor. The fermented foods include soy sauce, soybean paste, and red pepper paste. The canned foods include canned seafood (for example, canned tuna, mackerel, saury, conch, etc.), canned livestock (canned beef, pork, chicken, turkey, etc.), and canned agricultural products (canned corn, peaches, pile apple, etc.). The milk processed foods include cheese, butter, and yogurt. The processed meat foods include pork cutlet, beef cutlet, chicken cutlet, sausage, sweet and sour pork, nuggets, neobiani, etc. The processed noodles include dried noodles, thin noodles, ramen, udon noodles, cold noodles, sealed packaged fresh noodles, etc. In addition, the composition may be used for retort foods, soups, and the like.
The term “health functional food” of the present invention, as the same term as food for special health use (FoSHU), refers to foods with high medical and health effects that have been processed to efficiently show a body modulating function in addition to supplying nutrients. The foods may be produced in various forms such as tablets, capsules, powders, granules, liquids, pills, etc., in order to obtain a useful effect in promoting height growth.
The composition for promoting height growth of the present invention may comprise the Humulus japonicus ingredient in an amount of 0.1 to 100 wt %, more preferably 20 to 99 wt %, based on the total weight of the composition.
The composition for promoting height growth of the present invention may comprise the Humulus japonicus ingredient and at least one selected from the group consisting of watermelon and garlic in an amount of 0.1 to 100 wt %, more preferably 20 to 99 wt %, based on the total weight of the composition.
The composition for promoting height growth of the present invention may be administered in an amount of 1 mg to 30 g once based on the used amount of Humulus japonicus, and may be administered 2 to 3 times a day. Specifically, in the case of the extract, the extract prepared by using the Humulus japonicus in the content range may be considered as a single and daily dose. However, the present invention is not limited thereto, and may be determined by comprehensively considering various situations as described above.
The composition for promoting height growth of the present invention provides an effect of activating the proliferation of MG63 cells. In addition, the composition for promoting height growth increases ALP and osteocalcin (OC) gene expression in MG63 cells, and provides an effect of increasing the concentration of IGF-1 protein.
The ALP and osteocalcin are genes related to bone formation and are known to increase activities thereof when bone growth occurs actively, and the osteocalcin is a protein synthesized by osteoblasts during bone remodeling and bound to the extracelluar matrix of the bone.
The IGF-1 protein is an ingredient produced and secreted by growth hormones.
Hereinafter, the present invention will be described in more detail with reference to Examples. However, the following Examples are for explaining the present invention in more detail, and the scope of the present invention is not limited by the following Examples. The following Examples can be appropriately modified and changed by those skilled in the art within the scope of the present invention.
100 g of leaves and sprouts of Humulus japonicus were added with 2 L of distilled water and extracted with hot water at 90° C. for 5 hours. The extract was filtered, and the filtered extract solution was concentrated under reduced pressure at 50° C. to obtain a powdered sample through freeze-drying. At this time, the yield was 16.3 wt %.
100 g of leaves and sprouts of Humulus japonicus were added with 2 L of 50% ethanol and extracted at 50° C. for 5 hours. The extract was filtered, and the filtered extract solution was concentrated under reduced pressure at 40° C. to obtain a powdered sample through freeze-drying. At this time, the yield was 15.2 wt %.
100 g of leaves and sprouts of Humulus japonicus were added with 2 L of 99% acetone and extracted at 50° C. for 5 hours. The extract was filtered, and the filtered extract solution was concentrated under reduced pressure at 40° C. to obtain a powdered sample through freeze-drying. At this time, the yield was 3.7 wt %.
100 g of leaves and sprouts of Humulus japonicus were added with 2 L of 99% ethyl acetate and extracted at 0° C. for 5 hours. The extract was filtered, and the filtered extract solution was concentrated under reduced pressure at 40° C. to obtain a powdered sample through freeze-drying. At this time, the yield was 4.2 wt %.
16 kg of peeled garlic and 8 kg of seed-removed watermelon juice were heated in a high-pressure gas cooker under a pressure of 1 to 1.5 kg for 16 hours, and then dried and powdered.
The hot water extract powder of Humulus japonicus prepared in Example 1 and the watermelon/garlic concentrate powder prepared in Example 5 were mixed in a composition ratio of Table below to prepare a composition containing the Humulus japonicus extract and the watermelon/garlic concentrate.
In Experimental Example 1, the following experiment was performed to confirm effects of Humulus japonicus extracts in Examples 1 to 4 of the present invention and a watermelon/garlic concentrate sample in Example 5 on cytotoxicity.
1×104 MG63 cells were dispensed into a 96 well plate, and a DMEM containing 10% FBS was used as a culture medium. After incubation for 12 hours, each extract and the watermelon/garlic concentrate were treated with 100 to 1000 μg/mL and incubated for 24 hours. Thereafter, 20 μL of a WST reagent was added to block light with a foil to minimize WST reduction by light and reacted for 3 hours. The optical density was measured at a wavelength of 560 nm using an iMARK™ Microplate reader (Bio-Rad Laboratories Headquarters, Hercules, Calif., USA), and the results were shown in Table 2 below.
As shown in Table 2 below, as a result of evaluating the cytotoxicity of each sample by ED50 (a concentration at which cell viability becomes 50%), an ethyl acetate extract showed toxicity at the lowest concentration of 350.6 μg/mL.
Therefore, it was shown that all test ingredients were safe at concentrations below 350 μg/mL.
The following experiment was performed to confirm effects of the Humulus japonicus extracts in Examples 1 to 4 of the present invention and the watermelon/garlic concentrate sample in Example 5 on proliferation of MG63 cells.
1×104 MG63 cells were dispensed into a 96 well plate, and a DMEM containing 10% FBS was used as a culture medium. After incubation for 12 hours, each Humulus japonicus extract and the watermelon/garlic concentrate were treated with 100 μg/mL and incubated for 24 hours. Thereafter, 20 μL of a WST reagent was added to block light with a foil to minimize WST reduction by light and reacted for 3 hours. The optical density was measured at a wavelength of 560 nm using an iMARK™ Microplate reader (Bio-Rad Laboratories Headquarters, Hercules, Calif., USA).
The results of evaluating cell proliferation of respective samples were shown in
The following experiment was performed to confirm effects of the Humulus japonicus extracts in Examples 1 to 4 of the present invention and the watermelon/garlic concentrate sample in Example 5 on the expression of ALP and OC genes and the concentration of IGF-1 protein in MG63 cells.
5×105 MG63 cells were dispensed into a 12 well plate, treated with 100 μg/M1 of the Humulus japonicus extracts and the watermelon/garlic concentrate for 24 hours, and then the cells were collected and RNA extraction was performed according to a manufacturer's protocol by using an RNeasy extraction kit (Qiagen, Gaithersburg, Md., USA). cDNA was synthesized by using an iScript cDNA synthesis kit (Bio-Rad Laboratories Headquarters, Hercules, Calif., USA). Real-time quantitative PCR was performed using SYBR Green (iQ SYBR Green Supermix, Bio-Rad Laboratories Inc.) to measure the expression of genes, and as an instrument, Real-Time PCR (Applied Biosystems, Foster City, Calif., USA) was used. The nucleotide sequences of the genes to be measured were shown in Table 3 below.
For real time PCR reaction, 2 μL of cDNA and 10 μL of 2×SYBR mix were added in a total of 20 μL, and 100 pmol/μL of forward and reverse primers were added by 1 μL, respectively, and the remaining primers were filled with H2O. Amplification was performed through a PCR amplification step as follows, and 40 cycles of amplification cycle were performed. In other words, hot start at 95° C. for 8 minutes, denaturation in the amplification step at 95° C. for 15 seconds, annealing at 55° C. for 30 seconds, and extension at 72° C. for 30 seconds were repeated, and the values were recorded after the extension of each cycle. After all cycles were completed, melting curve analysis was performed to confirm the specificity of the primers. The results were analyzed with One step system software v2.1 provided by Applied Biosystems. The concentration of IGF-1 protein was measured using an enzyme assay kit (Crystal Chem, IL, USA) according to a manufacturer's protocol.
As a result of measuring ALP gene expression, as shown in
As a result of measuring OC gene expression, as shown in
As a result of measuring the concentration of the IGF-1 protein, as shown in
In order to confirm effects of treatment of the compositions containing the Humulus japonicus extract and the watermelon/garlic concentrate in Examples 6 to 8 of the present invention prepared by varying a mixing ratio on proliferation of MG63 cells, respectively, the following experiment was performed.
1×104 MG63 cells were dispensed into a 96 well plate, and a DMEM containing 10% FBS was used as a culture medium. After incubation for 12 hours, the compositions containing the hot water extract of Humulus japonicus and the watermelon/garlic concentrate [weight ratio of Humulus japonicus extract and watermelon/garlic concentrate=2:8 (Example 6), 5:5 (Example 7), 8:2 (Example 8)] were treated with 10, 50, and 100 μg/mL, respectively, and incubated for 24 hours. The following experimental method was performed in the same manner as in Experimental Example 3.
As a result of performing the experiment, as shown in
In order to confirm effects of treatment of the compositions containing the Humulus japonicus extract and the watermelon/garlic concentrate in Examples 6 to 8 of the present invention prepared by varying a mixing ratio on ALP, OC, and IGF-1 genes in MG63 cells, respectively, the following experiment was performed.
5×105 MG63 cells were dispensed into a 12 well plate, and the compositions containing the hot water extract of Humulus japonicus and the watermelon/garlic concentrate [weight ratio of Humulus japonicus extract and watermelon/garlic concentrate=2:8 (Example 6), 5:5 (Example 7), 8:2 (Example 8)] were treated with 10, 50, and 100 μg/mL for 24 hours, respectively. Then, the cells were collected and RNA extraction was performed by a RNeasy extraction kit (Qiagen, Gaithersburg, Md., USA) according to a manufacturer's protocol. The following experimental method was the same as in Experimental Example 4.
As a result of measuring ALP gene expression, as shown in
As a result of measuring the expression of the OC gene, as shown in
In addition, in the groups treated with the compositions containing the hot water extract of Humulus japonicus and the watermelon/garlic concentrate in Examples 6 to 8, the expression level of the OC gene was more increased than that of the single treated group of the hot water extract of Humulus japonicus in Example 1. Particularly, among the composition treated groups, it was confirmed that as the content of the hot water extract of Humulus japonicus was higher and the treated concentration of the sample was higher, the expression level of the OC gene was more increased.
As a result of measuring the concentration of the IGF-1 protein, as shown in
In addition, in the groups treated with the compositions containing the hot water extract of Humulus japonicus and the watermelon/garlic concentrate in Examples 6 to 8, the concentration of the IGF-1 protein was higher than that of the single treated group of the hot water extract of Humulus japonicus in Example 1. Particularly, among the composition treated groups, it was confirmed that as the content of the hot water extract of Humulus japonicus was higher and the treated concentration of the sample was higher, the concentration of the IGF-1 protein was higher.
In Experimental Example 6, the following experiment was performed in order to confirm an effect on the height growth of SD rats when the hot water extract of Humulus japonicus of the present invention and the watermelon/garlic concentrate were treated by varying a mixing ratio.
3-week-old SD rats were supplied by Saeron Bio Co., Ltd. and adapted to a surrounding environment for 1 week under certain conditions (temperature: 23±2° C., relative humidity: 50±5%, contrast: 12 hours light/dark cycle) in an animal breeding room and then used. For animals determined to be healthy during the adaptation period, subjects close to an average weight were selected, and groups were divided using 6 rats per group using a random method.
The groups were divided into a normal control (NC), a control (recombinant growth hormone; growth hormone administered group), 50 mg/kg B.W. of the hot water extract of Humulus japonicus of Example 1; 100 mg/kg B.W. of the hot water extract of Humulus japonicus of Example 1; 50 mg/kg B.W. of the watermelon/garlic concentrate of Example 5; 100 mg/kg B.W. of the watermelon/garlic concentrate of Example 5; 50 mg/kg B.W. of the composition containing the hot water extract of Humulus japonicus and the watermelon/garlic concentrate of Example 6 (weight ratio=20:80); 100 mg/kg B.W. of the composition containing the hot water extract of Humulus japonicus and the watermelon/garlic concentrate of Example 6 (weight ratio=20:80); 50 mg/kg B.W. of the composition containing the hot water extract of Humulus japonicus and the watermelon/garlic concentrate of Example 7 (weight ratio=50:50); 100 mg/kg B.W. of the composition containing the hot water extract of Humulus japonicus and the watermelon/garlic concentrate of Example 7 (weight ratio=50:50); 50 mg/kg B.W. of the composition containing the hot water extract of Humulus japonicus and the watermelon/garlic concentrate of Example 8 (weight ratio=80:20); and 100 mg/kg B.W. of the composition containing the hot water extract of Humulus japonicus and the watermelon/garlic concentrate of Example 8 (weight ratio=80:20). AIN93G diet and drinking water were supplied freely for 3 weeks. During the experimental period, the body weights and animal lengths (nose-anus length and nose-tail length) were measured every week at a certain time, and the results were shown in Table 4 below.
0.60de
0.19de
0.67ef
0.53ef
0.65ef
0.77ef
0.63ef
0.28ef
0.46cd
0.24bc
As shown in Table 4, as a result of measuring the body lengths of the experimental animals after oral administration of each sample, it was confirmed that in a control group administered with a growth hormone, compared to a normal group without administration of the sample, a length from nose to hip was significantly increased by 22.98 to 37.54%, and a length from nose to tail was also significantly increased by 21.27 to 37.34%. In the sample administered group in Example of the present invention, compared to the normal group, the length from the nose to the hip was significantly increased by 26.05 to 36.48% and the length from the nose to the tail was also significantly increased by 25.88 to 36.32%.
Specifically, as in the cell experiment, when the hot water extract of Humulus japonicus of Example 1 was administered alone, compared to the case where the watermelon/garlic concentrate of Example 5 was administered alone, a better length increase was shown.
In addition, in the groups treated with the compositions containing the hot water extract of Humulus japonicus and the watermelon/garlic concentrate in Examples 6 to 8, the increase in lengths of the experimental animals was greater than that of a single treated group of the hot water extract of Humulus japonicus.
Particularly, among the composition treated groups, it was confirmed that as the content of the hot water extract of Humulus japonicus was higher and the treated concentration of the sample was higher, the increase in lengths of the experimental animals was greater.
| Number | Date | Country | Kind |
|---|---|---|---|
| 10-2019-0050164 | Apr 2019 | KR | national |
| Filing Document | Filing Date | Country | Kind |
|---|---|---|---|
| PCT/KR2019/010687 | 8/22/2019 | WO |
| Publishing Document | Publishing Date | Country | Kind |
|---|---|---|---|
| WO2020/222366 | 11/5/2020 | WO | A |
| Number | Name | Date | Kind |
|---|---|---|---|
| 6900281 | Streeky | May 2005 | B2 |
| 20140377383 | Sun et al. | Dec 2014 | A1 |
| 20180078525 | Kim et al. | Mar 2018 | A1 |
| Number | Date | Country |
|---|---|---|
| 101548708 | Oct 2009 | CN |
| 101642193 | Feb 2010 | CN |
| 103432364 | Dec 2013 | CN |
| 103609900 | Mar 2014 | CN |
| 103919932 | Jul 2014 | CN |
| 104256690 | Jan 2015 | CN |
| 106615634 | May 2017 | CN |
| 107410728 | Dec 2017 | CN |
| 108114207 | Jun 2018 | CN |
| 109418563 | Mar 2019 | CN |
| 10-2004-0092861 | Nov 2004 | KR |
| 10-2008-0109359 | Dec 2008 | KR |
| 10-2011-0055940 | May 2011 | KR |
| 10-1043509 | Jun 2011 | KR |
| 10-1067028 | Sep 2011 | KR |
| 10-2013-0102295 | Sep 2013 | KR |
| 10-2014-0019707 | Feb 2014 | KR |
| 10-2014-0057709 | May 2014 | KR |
| 10-2016-0025073 | Mar 2016 | KR |
| 10-2017-0000902 | Jan 2017 | KR |
| 2015009047 | Jan 2015 | WO |
| WO-2016006947 | Jan 2016 | WO |
| Entry |
|---|
| Lee et al. (2012) Korean J. Food and Nutr. vol. 25, No. 2, pp. 357-361. (Year: 2012). |
| Raskin et al. (2004) Current Pharmaceutical Design 10, 3419-3429. (Year: 2004). |
| Revilla et al. (1998) J. Agric. Food Chem. 46, 4592-4597. (Year: 1998). |
| Seung-Woo Park, et al., “Antimutagenic Effects and Isolation of Flavonoids from Humulus japonicus Extract”, Korean J. Food Sci. Technol, 1995, pp. 897-901, vol. 27, No. 6. |
| Tae-Ho Kim, et al., “The effects of luteolin on osteoclast differentiation, function in vitro and ovariectomy-induced bone loss”, Journal of Nutritional Biochemistry, 2011, pp. 8-15, vol. 22. |
| Christophe Prouillet, et al., “Stimulatory effect of naturally occurring flavonols quercetin and kaempferol on alkaline phosphatase activity in MG-63 human osteoblasts through ERK and estrogen receptor pathway”, Biochemical Pharmacology, 2004, pp. 1307-1313, vol. 67. |
| M. Mukherjee, et al., “Prevention of Bone Loss by Oil Extract of Garlic (Allium sativum Linn.) in an Ovariectomized Rat Model of Osteoporosis”, Phytotherapy Research, 2004, pp. 389-394, vol. 18. |
| Maryam Mahmood, “The Effects of Freeze-Dried Watermelon On Bone and Clinical Parameters of Ovariectomized Mice”, Thesis of the degree of master of science, Benedictine University, 2011, 73 pages. |
| International Search Report for PCT/KR2019/010687 dated Jan. 29, 2020 (PCT/ISA/210). |
| Extended European Search Report issued in EP application No. 19927281.6, dated Nov. 21, 2022. |
| Number | Date | Country | |
|---|---|---|---|
| 20210252089 A1 | Aug 2021 | US |
